Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma
- PMID: 8094976
- PMCID: PMC1968256
- DOI: 10.1038/bjc.1993.101
Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma
Abstract
Investigation of genetic changes in tumours by loss of heterozygosity (LOH) is a powerful technique for identifying chromosomal regions that may contain tumour suppressor genes. LOH has been described on chromosome 6 in ovarian carcinoma using restriction fragment length polymorphism analysis with a small number of probes. We studied 29 ovarian carcinomas with 19 probes mapping to chromosome 6. Sixteen of the 29 tumours showed LOH on 6q (55%). Of these 16, 63% showed loss of all informative markers on that arm. One tumour showed loss of 6q24-qter, localising the putative tumour suppressor gene to that region. Loss on 6p was 28% overall. However, using three dinucleotide repeat primer pairs from 6p to study LOH in seven selected tumours, LOH was demonstrated at both 6p22.3-pter and at 6p12-6p22. These results confirm that 6q harbours a tumour suppressor gene of relevance to ovarian carcinoma and suggest that there may also be a similar gene(s) on 6p. By Southern analysis, there was no evidence of genomic rearrangements of the oestrogen receptor gene, located at 6q25.1. LOH on 6q was more common in high than low grade tumours. The relevance of our findings to previous work in ovarian cancer and other solid tumours is discussed.
Similar articles
-
A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas.Oncogene. 1998 Jan 29;16(4):555-9. doi: 10.1038/sj.onc.1201523. Oncogene. 1998. PMID: 9484846
-
A common region of deletion on chromosome 17q in both sporadic and familial epithelial ovarian tumors distal to BRCA1.Am J Hum Genet. 1994 Oct;55(4):666-77. Am J Hum Genet. 1994. PMID: 7942844 Free PMC article.
-
Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma.Int J Cancer. 1993 May 8;54(2):220-5. doi: 10.1002/ijc.2910540210. Int J Cancer. 1993. PMID: 8098014
-
Tumour suppressor genes in sporadic epithelial ovarian cancer.Reproduction. 2002 Mar;123(3):341-53. doi: 10.1530/rep.0.1230341. Reproduction. 2002. PMID: 11882011 Review.
-
The genetic analysis of ovarian cancer.Br J Cancer. 1995 Sep;72(3):521-7. doi: 10.1038/bjc.1995.367. Br J Cancer. 1995. PMID: 7669555 Free PMC article. Review. No abstract available.
Cited by
-
Failure in post-transcriptional processing is a possible inactivation mechanism of AP-2alpha in cutaneous melanoma.Br J Cancer. 2000 Jun;82(12):2015-21. doi: 10.1054/bjoc.2000.1145. Br J Cancer. 2000. PMID: 10864211 Free PMC article.
-
Involvement of chromosome 6 in endometrial cancer.Br J Cancer. 1997;75(12):1831-5. doi: 10.1038/bjc.1997.312. Br J Cancer. 1997. PMID: 9192990 Free PMC article.
-
Homozygous deletions on the short arm of chromosome 9 in ovarian adenocarcinoma cell lines and loss of heterozygosity in sporadic tumors.Am J Hum Genet. 1994 Jul;55(1):143-9. Am J Hum Genet. 1994. PMID: 8023842 Free PMC article.
-
Proximal 6q, a region showing allele loss in primary breast cancer.Br J Cancer. 1995 Feb;71(2):290-3. doi: 10.1038/bjc.1995.58. Br J Cancer. 1995. PMID: 7841042 Free PMC article.
-
Ubiquitin-related gene markers predict immunotherapy response and prognosis in patients with epithelial ovarian carcinoma.Sci Rep. 2024 Oct 24;14(1):25239. doi: 10.1038/s41598-024-76945-2. Sci Rep. 2024. PMID: 39448713 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical